Tanaka N, Fujimoto K, Hirayama A, Yoneda T, Yoshida K, Hirao Y: Trends of the primary therapy for patients with prostate cancer in Nara uro-oncological research group (NUORG): a comparison between the CaPSURE data and the NUORG data. Jpn J Clin Oncol. 2010, 40: 588-592. 10.1093/jjco/hyq008.
Article
PubMed
Google Scholar
Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR: CaPSURE: time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol. 2003, 170: S21-S27. 10.1097/01.ju.0000095025.03331.c6.
Article
PubMed
Google Scholar
Cancer Registration Committee of the Japanese Urological Association: Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol. 2005, 12: 46-61.
Article
Google Scholar
Hinotsu S, Akaza H, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Namiki M, Hirao Y, Murai M, Yamanaka H: Japan study group of prostate cancer (J-CaP): current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP. Jpn J Clin Oncol. 2007, 37: 775-781. 10.1093/jjco/hym098.
Article
PubMed
Google Scholar
D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998, 280: 969-974. 10.1001/jama.280.11.969.
Article
PubMed
Google Scholar
Fujimoto H, Nakanishi H, Miki T, Kubota Y, Takahashi S, Suzuki K, Kanayama HO, Mikami K, Homma Y: Oncological outcomes of the prostate cancer patients registered in 2004: report from the cancer registration committee of the JUA. Int J Urol. 2011, 18: 876-881. 10.1111/j.1442-2042.2011.02895.x.
Article
PubMed
Google Scholar
Cooperberg M, Lubeck DP, Penson D, Mehta SS, Carroll PR, Kane CJ: Sociodemographic and clinical risk characteristics of patients with prostate cancer within the veterans affairs health care system: data from CaPSURE. J Urol. 2003, 170: 905-908. 10.1097/01.ju.0000081200.63275.0b.
Article
PubMed
Google Scholar
Cooperberg MR, Broering JM, Kantoff PW, Carroll PR: Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007, 178: S14-S19. 10.1016/j.juro.2007.03.135.
Article
PubMed
PubMed Central
Google Scholar
Epstein JI, Allsbrook WC, Amin MB, Egevad LL, Grading ISUP: Committee: the international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005, 2005 (29): 1228-1242.
Article
Google Scholar
Cooperberg MR, Cowan J, Broering JM, Carroll PR: High-risk prostate cancer in the United States, 1990-2007. World J Urol. 2008, 26: 211-218. 10.1007/s00345-008-0250-7.
Article
PubMed
PubMed Central
Google Scholar
Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H: Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol. 2009, 27: 4306-4313. 10.1200/JCO.2008.21.5228.
Article
PubMed
PubMed Central
Google Scholar
Ito K, Kakehi Y, Naito S, Okuyama A, Japanese Urological Association: Japanese urological association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan. Int J Urol. 2008, 15: 763-768. 10.1111/j.1442-2042.2008.02125.x.
Article
PubMed
Google Scholar
Sirovich BE, Schwartz LM, Woloshin S: Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?. JAMA. 2003, 289: 1414-1420. 10.1001/jama.289.11.1414.
Article
PubMed
Google Scholar
Tanaka N, Fujimoto K, Hirayama A, Samma S, Momose H, Kaneko Y, Haramoto M, Hayashi Y, Nakagawa Y, Otani T, Watanabe S, Hirao Y: The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara uro-oncological research group registration. BMC Urol. 2011, 11: 6-10.1186/1471-2490-11-6.
Article
PubMed
PubMed Central
Google Scholar
Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, Pollack A: Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer: who dies of disease?. Int J Radiat Oncol Biol Phys. 2011, 79: 1310-1317. 10.1016/j.ijrobp.2010.01.006.
Article
PubMed
Google Scholar
Stone NN, Stone MM, Rosenstein BS, Unger P, Stock RG: Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy. J Urol. 2011, 185: 495-500. 10.1016/j.juro.2010.09.099.
Article
PubMed
Google Scholar